| Class 2 Device Recall Superstat Modified Collagen Hemostatic Sponge | |
Date Initiated by Firm | October 24, 2012 |
Date Posted | November 16, 2012 |
Recall Status1 |
Terminated 3 on February 06, 2013 |
Recall Number | Z-0340-2013 |
Recall Event ID |
63581 |
PMA Number | P810040 |
Product Classification |
Agent, absorbable hemostatic, collagen based - Product Code LMF
|
Product | Superstat Modified Collagen Hemostatic Sponge, 85mm x 85mm Pledget, 1.5%, Part# 9300-15.
For use when hemostasis is desired along suture lines, in diffusely bleeding sites, in incisions, dissections, and around arterial or venous anastomoses. Indicated in oozing bleeding, either capillary or venous, in almost all types of incisions or wounds, and as an adjunct to conventional closure techniques |
Code Information |
Lot# SSK07P. |
Recalling Firm/ Manufacturer |
Superstat Corp 2015 E University Dr Rancho Dominguez CA 90220-6411
|
For Additional Information Contact | 310-605-1655 |
Manufacturer Reason for Recall | The recall was initiated because Superstat Corporation has confirmed that no documentation are available to verify that quarterly dose sterility audits were performed for the Superstat Modified Collagen Hemostatic Sponge. |
FDA Determined Cause 2 | Process control |
Action | Superstat initially contacted customers by telephone and sent an Urgent - Device Recall Notification Letter on October 24, 2012, to all affected customers. The recall letter provided the reason for recall was due to inadequate documentation of quarterly dose sterility audits. The recall includes all lots and part numbers of Superstat produced between 2002 and 2012. Customers are instructed to complete and return the enclosed response form as soon as possible. Customers with questions are instructed to call customer service at (800) 487-3786.
For questions regarding this recall call 310-605-1655. |
Quantity in Commerce | 26,422 units |
Distribution | Worldwide Distribution - USA (nationwide) and the countries of Saudi Arabia, Thailand, Mexico, Canada, Pakistan, Israel, Greece, Serbia, Canda, Isle of Man, Nova Scotia, and Singapore. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
PMA Database | PMAs with Product Code = LMF
|
|
|
|